|
n (%)
|
---|
Inducible MLSB
|
5 (2.7%)
|
Constitutive MLSB
|
8 (4.3%)
|
Macrolide resistance only
|
2 (1.1%)
|
Clindamycin resistance only
|
3 (1.6%)
|
Macrolide–lincosamide susceptible
|
168 (90.3%)
|
Total
|
186 (100%)
|
-
MLS
B
Macrolide–lincosamide–streptogramin B resistance phenotype